Chronic Myeloid Leukemia in Adolescents and Young Adults Treated with Generic Form of Imatinib in Resource Limited Setting: A Single Center Experience from Myanmar

被引：0
|
作者：
Han, Yin Nwe [1 ]
Gyi, Aye Aye [1 ,2 ]
Htut, Khin Thida [2 ]
机构：
[1] North Okkalapa Gen & Teaching Hosp, Dept Clin Haematol, Yangon, Myanmar
[2] North Okkalapa Gen & Teaching Hosp, Yangon, Myanmar
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-120298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5451
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Efficacy and Safety of Generic Imatinib after Switching from Innovator Imatinib in Patients Treated for Chronic Myeloid Leukemia
    Aboudalle, Iman
    Kantarjian, Hagop M.
    Burger, Jan A.
    Estrov, Zeev
    Ohanian, Maro
    Jabbour, Elias J.
    Verstovsek, Srdan
    Ravandi, Farhad
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    BLOOD, 2017, 130
  • [12] Experience of Generic Imatinib As a First Line Therapy for Patients with Chronic Myeloid Leukemia in a Single Reference Institution
    Pereira, Gabriel Carvalho
    da Silva, Fernanda B.
    Oliveira, Luisa Espirito Santo
    Garibaldi, Pedro Marques
    Figueiredo-Pontes, Lorena Lobo
    Simoes, Belinda Pinto
    Palma, Leonardo Carvalho
    Traina, Fabiola
    BLOOD, 2019, 134
  • [13] Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India
    Ganguly, Shuvadeep
    Pushpam, Deepam
    Mian, Agrima
    Chopra, Anita
    Gupta, Ritu
    Bakhshi, Sameer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : E437 - E444
  • [14] Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience
    Dukovski, Dushko
    Trajkova, Sanja
    Stojanovska, Simona
    Ridova, Nevenka
    Panovska-Stavridis, Irina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S232 - S232
  • [15] Incidence of imatinib resistance in chronic myeloid leukemia (CML) patients: Experience from resource poor center of eastern India
    Bhattacharyya, D.
    Ghosh, R.
    Gupta, P.
    Gupta, A.
    Roychoudhury, S.
    Nath, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [16] Chronic Myeloid Leukemia (CML) in Adolescents & Young Adults (AYA): Single Institution 10 Years Experience with 1st Line Imatinib Mesylate (IM)
    Malhotra, Hemant
    Yadav, Ajay
    Gupta, Naveen
    Soni, Satyajeet
    Singh, Jitender Kumar
    Malhotra, Bharti
    BLOOD, 2020, 136
  • [17] Efficacy and Safety of Generic Imatinib in Chronic Phase of Chronic Myeloid Leukemia (CP-CML): Experience from a Multi-Center in China
    Zhou, Li
    Liu, Bingcheng
    Hu, Jianda
    Qu, Jianhua
    Hou, Ming
    Sun, Hui
    Jin, Jie
    Shen, Zhixiang
    BLOOD, 2019, 134
  • [18] EVALUATION OF THE EFFECTIVENESS AND TOXICITY OF GLIVEC AND GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. REVIEW IN A SINGLE CENTER
    Vilaseca, Creus Xavier
    Ramila, Herrero Maria Elena
    Piedra, Sanchez Jordi
    Soriano, Gutierrez Laura
    Segura, de laTorre Laura
    Martinez, de Sola Montserrat
    Piernas, Pontanillas Sonia
    Gomez, Nunez Marta
    Soler, Campos
    Juan, Alfonso
    Roig, Martinez Immaculada
    HAEMATOLOGICA, 2020, 105 : 247 - 247
  • [19] Survival Outcome of Imatinib Mono Therapy in Chronic Phase Chronic Myeloid Leukemia - a Single Center Experience in Belorus
    Kozich, Janna
    Lomaia, Elza
    Zaritskey, Andrey
    BLOOD, 2016, 128 (22)
  • [20] Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia-Single Center Retrospective Analysis
    Bhatwadekar, Seema Shrinivas
    Deshpande, Shubhangi Vishwas
    Mehta, Arpan
    Shah, Parth
    BLOOD, 2019, 134
12345